Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP & Controller | July 24, 2008 | July 25, 2008 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date July 24, 2008 · Filed July 25, 2008
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2018-07-23 | Direct | 7,500 |
Reported balance
After 2008-07-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2008-07-24 · Grant · Acquired 7,500 · Balance 7,500 F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2008 Filed Jul 25, 2008 15:04 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Options · Derivative | 7,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000055 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| February 07, 2008 Filed Feb 11, 2008 20:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 11,250 | $0.00 Strike: $18.93 | $0.00 |
DisclosureSEC source: 0000875320-08-000006 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2018-02-06 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval. Read SEC document |
| February 07, 2008 Filed Feb 11, 2008 20:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 2,500 | $0.01 | $25.00 |
DisclosureSEC source: 0000875320-08-000006 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,055 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| December 12, 2007 Filed Dec 13, 2007 15:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7 | $25.45 | $178.15 |
DisclosureSEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,555 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 12, 2007 Filed Dec 13, 2007 15:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1 | $25.42 | $25.42 |
DisclosureSEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,562 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 12, 2007 Filed Dec 13, 2007 15:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1 | $25.41 | $25.41 |
DisclosureSEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,563 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 27 | $26.19 | $707.13 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 7 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 27 | $26.12 | $705.24 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,591 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 27 | $26.05 | $703.35 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,618 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 27 | $25.97 | $701.19 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,645 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 54 | $25.96 | $1,401.84 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,672 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 28 | $25.93 | $726.04 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 16, 2007 Filed Nov 19, 2007 19:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 81 | $25.83 | $2,092.23 |
DisclosureSEC source: 0000875320-07-000110 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,754 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000102 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,213 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $32.44 | $4,055.00 |
DisclosureSEC source: 0000875320-07-000102 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000102 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2007 Filed Oct 23, 2007 17:31 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000101 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,338 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 22, 2007 Filed Oct 23, 2007 17:31 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.23 | $3,778.75 |
DisclosureSEC source: 0000875320-07-000101 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 22, 2007 Filed Oct 23, 2007 17:31 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000101 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2007 Filed Oct 16, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000100 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,463 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 15, 2007 Filed Oct 16, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $36.05 | $4,506.25 |
DisclosureSEC source: 0000875320-07-000100 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 15, 2007 Filed Oct 16, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000100 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2007 Filed Oct 9, 2007 15:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000099 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,588 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 08, 2007 Filed Oct 9, 2007 15:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $36.47 | $4,558.75 |
DisclosureSEC source: 0000875320-07-000099 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 08, 2007 Filed Oct 9, 2007 15:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000099 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2007 Filed Oct 2, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000098 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,713 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 01, 2007 Filed Oct 2, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $38.77 | $4,846.25 |
DisclosureSEC source: 0000875320-07-000098 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| October 01, 2007 Filed Oct 2, 2007 17:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000098 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2007 Filed Sep 25, 2007 16:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000097 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,838 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 24, 2007 Filed Sep 25, 2007 16:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $38.21 | $4,776.25 |
DisclosureSEC source: 0000875320-07-000097 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| September 24, 2007 Filed Sep 25, 2007 16:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000097 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2007 Filed Sep 20, 2007 18:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 200 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000096 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,963 Underlying: Common Stock · 200 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 19, 2007 Filed Sep 20, 2007 18:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 200 | $40.00 | $8,000.00 |
DisclosureSEC source: 0000875320-07-000096 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| September 19, 2007 Filed Sep 20, 2007 18:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 200 | $13.11 | $2,622.00 |
DisclosureSEC source: 0000875320-07-000096 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2007 Filed Sep 19, 2007 13:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 50 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000095 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 Underlying: Common Stock · 50 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 17, 2007 Filed Sep 19, 2007 13:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 50 | $40.04 | $2,002.00 |
DisclosureSEC source: 0000875320-07-000095 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| September 17, 2007 Filed Sep 19, 2007 13:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 50 | $13.11 | $655.50 |
DisclosureSEC source: 0000875320-07-000095 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2007 Filed Sep 11, 2007 19:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000094 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 10, 2007 Filed Sep 11, 2007 19:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $39.60 | $4,950.00 |
DisclosureSEC source: 0000875320-07-000094 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| September 10, 2007 Filed Sep 11, 2007 19:08 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000094 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 18:10 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000092 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,338 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 18:10 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $39.42 | $4,927.50 |
DisclosureSEC source: 0000875320-07-000092 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 18:10 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000092 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000091 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $37.31 | $4,663.75 |
DisclosureSEC source: 0000875320-07-000091 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000091 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 14:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000090 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,588 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 14:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $36.26 | $4,532.50 |
DisclosureSEC source: 0000875320-07-000090 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 14:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000090 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2007 Filed Aug 14, 2007 17:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000089 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,713 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.